FT. MYERS, FL - (ACCESSWIRE - October 22, 2013) - NeoGenomics, Inc. (NEO) will host a live webcast to discuss the results of the third quarter, to be held Wednesday, October 23, 2013 at 11:00 a.m. Eastern Time.
To participate in this event, dial (877) 407-8035 domestically, or (201) 689-8035 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at http://www.investorcalendar.com/IC/CEPage.asp?ID=171755.
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=171755 or http://www.investorcalendar.com/, as well as via the NeoGenomics web site (http://www.neogenomics.com/).
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing.
Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA, Tampa and Fort Myers, FL. NeoGenomics services the needs of pathologists, oncologists, other clinicians and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.com/.
- Company Earnings